Arcus Biosciences Inc.(RCUS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RCUS Arcus Biosciences Inc.

盘前交易 12-20 09:06:14 EST

15.46

+0.29

+1.91%

盘前14.87

-0.59-3.82%

04:11 EST

最高15.75	最低14.78	成交量65.89万
今开15.17	昨收15.17	日振幅6.43%
总市值14.15亿	流通市值7.96亿	总股本9,151万
成交额1,013万	换手率1.28%	流通股本5,148万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RCUS","market":"US","secType":"STK","nameCN":"Arcus Biosciences Inc.","latestPrice":15.46,"timestamp":1734642000000,"preClose":15.17,"halted":0,"volume":658854,"hourTrading":{"tag":"盘前","latestPrice":14.87,"preClose":15.46,"latestTime":"04:11 EST","volume":1,"amount":14.87,"timestamp":1734685864035},"delay":0,"floatShares":51479306,"shares":91511609,"eps":-3.140697,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.29,"latestTime":"12-20 09:06:14 EST","open":15.17,"high":15.75,"low":14.775,"amount":10126262.482686,"amplitude":0.064272,"askPrice":15.46,"askSize":275,"bidPrice":14.57,"bidSize":6,"shortable":3,"etf":0,"ttmEps":-3.140697,"exchange":"NYSE","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734705000000},"adr":0,"listingDate":1521086400000,"adjPreClose":15.46,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":14.87,"preClose":15.46,"latestTime":"04:11 EST","volume":1,"amount":14.87,"timestamp":1734685864035},"postHourTrading":{"tag":"盘后","latestPrice":15.46,"preClose":15.46,"latestTime":"17:23 EST","volume":19593,"amount":302898.685,"timestamp":1734647011846},"volumeRatio":0.8426960688137566,"impliedVol":1.2002,"impliedVolPercentile":0.9442},"requestUrl":"/m/hq/s/RCUS","defaultTab":"news","newsList":[{"id":"2492379151","title":"Arcus Biosciences, Inc.盘中异动 临近收盘股价大跌5.04%报15.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492379151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492379151?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:32","pubTimestamp":1734553926,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时32分，Arcus Biosciences, Inc.股票出现异动，股价大幅下跌5.04%。截至发稿，该股报15.27美元/股，成交量51.2952万股，换手率0.56%，振幅6.41%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为2.40%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。Arcus针对不同类型的癌症进行临床试验，如肺癌、结肠直肠癌、胰腺癌等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219043206984cb85c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219043206984cb85c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"2491301068","title":"Arcus Biosciences, Inc.盘中异动 快速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491301068","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491301068?lang=zh_cn&edition=full","pubTime":"2024-12-14 02:38","pubTimestamp":1734115111,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日02时38分，Arcus Biosciences, Inc.股票出现波动，股价快速下挫5.01%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Innate Pharma、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Aptevo Therapeutics Inc.、Palisade Bio, Inc.、Candel Therapeutics, Inc.较为活跃，换手率分别为120.42%、95.95%、46.47%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Innate Pharma，振幅分别为76.77%、65.55%、64.52%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121402383195e981bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121402383195e981bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCUS"],"gpt_icon":0},{"id":"2491533176","title":"Arcus Biosciences, Inc.盘中异动 急速下挫5.01%报17.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491533176","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491533176?lang=zh_cn&edition=full","pubTime":"2024-12-13 00:28","pubTimestamp":1734020931,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日00时28分，Arcus Biosciences, Inc.股票出现异动，股价大幅下跌5.01%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.97%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Palisade Bio, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为3493.01%、892.28%、77.85%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为129.16%、86.92%、80.04%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121300285195e93b5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121300285195e93b5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCUS"],"gpt_icon":0},{"id":"2489255403","title":"Arcus Biosciences, Inc.盘中异动 临近午盘股价大涨5.20%报18.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489255403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489255403?lang=zh_cn&edition=full","pubTime":"2024-12-07 00:56","pubTimestamp":1733504183,"startTime":"0","endTime":"0","summary":"北京时间2024年12月07日00时56分，Arcus Biosciences, Inc.股票出现异动，股价快速上涨5.20%。截至发稿，该股报18.00美元/股，成交量8.2333万股，换手率0.09%，振幅5.73%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。Arcus针对不同类型的癌症进行临床试验，如肺癌、结肠直肠癌、胰腺癌等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207005623a1d9b4cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207005623a1d9b4cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCUS"],"gpt_icon":0},{"id":"2489111418","title":"Arcus Biosciences, Inc.盘中异动 大幅拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489111418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489111418?lang=zh_cn&edition=full","pubTime":"2024-12-05 00:54","pubTimestamp":1733331275,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日00时54分，Arcus Biosciences, Inc.股票出现波动，股价急速拉升5.11%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Cyclerion Therapeutics, Inc.、Exicure, Inc.、Heron Therapeutics, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为3312.68%、256.07%、130.98%，振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Apollomics Inc C/Wts 01/04/2028 、Eterna Therapeutics Inc.，振幅分别为237.89%、61.31%、55.22%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。Arcus针对不同类型的癌症进行临床试验，如肺癌、结肠直肠癌、胰腺癌等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205005435971ba728&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205005435971ba728&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCUS"],"gpt_icon":0},{"id":"2486007565","title":"Arcus Biosciences, Inc.盘中异动 快速拉升5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486007565","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486007565?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:22","pubTimestamp":1732634571,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日23时22分，Arcus Biosciences, Inc.股票出现异动，股价大幅拉升5.12%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Poseida Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Protagenic Therapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Poseida Therapeutics, Inc.、木薯科学较为活跃，换手率分别为26.50%、19.23%、19.13%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Protagenic Therapeutics, Inc.、Fate Therapeutics, Inc.，振幅分别为85.82%、42.94%、31.40%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126232251a2575e1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126232251a2575e1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"2485267691","title":"Arcus Biosciences, Inc.盘中异动 早盘股价大涨5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485267691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485267691?lang=zh_cn&edition=full","pubTime":"2024-11-22 23:19","pubTimestamp":1732288789,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日23时19分，Arcus Biosciences, Inc.股票出现波动，股价急速拉升5.53%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Replimune Group, Inc.、Virpax Pharmaceuticals, Inc.、奥麦罗制药涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1564.66%、110.42%、81.70%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为55.96%、45.86%、38.10%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。Arcus针对不同类型的癌症进行临床试验，如肺癌、结肠直肠癌、胰腺癌等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122231949abd7a7a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122231949abd7a7a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRPX","BK4007","BK4139","RCUS"],"gpt_icon":0},{"id":"2484906606","title":"Arcus Biosciences, Inc.盘中异动 大幅下跌5.03%报14.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484906606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484906606?lang=zh_cn&edition=full","pubTime":"2024-11-19 01:10","pubTimestamp":1731949836,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日01时10分，Arcus Biosciences, Inc.股票出现异动，股价急速跳水5.03%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Hcw Biologics Inc.、Geovax Labs Inc C/Wts 29/09/2025、冠科美博涨幅较大，Hcw Biologics Inc.、Tharimmune, Inc.、冠科美博较为活跃，换手率分别为1033.69%、564.37%、558.96%，振幅较大的相关个股有Hcw Biologics Inc.、Apollomics Inc C/Wts 01/04/2028 、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为482.01%、129.51%、91.09%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119011036a2436f8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119011036a2436f8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"2483060903","title":"Arcus Biosciences, Inc.盘中异动 急速跳水5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483060903","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483060903?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:52","pubTimestamp":1731685975,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时52分，Arcus Biosciences, Inc.股票出现波动，股价大幅下挫5.14%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为3.25%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Celularity Inc C/Wts 16/07/2026 、Cero Therapeutics Holdings, Inc.涨幅较大，Tc Biopharm  Plc、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为4202.64%、544.89%、342.75%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Celularity Inc C/Wts 16/07/2026 ，振幅分别为134.58%、129.73%、110.59%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115235256971a6e7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115235256971a6e7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"2483385689","title":"Arcus Biosciences, Inc.2024财年第三财季实现净利润-92.00百万美元，同比减少29.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483385689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483385689?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:02","pubTimestamp":1731600127,"startTime":"0","endTime":"0","summary":"11月15日，Arcus Biosciences, Inc.公布财报，公告显示公司2024财年第三财季净利润为-92.00百万美元，同比减少29.58%；其中营业收入为48.00百万美元，同比增加50.00%，每股基本收益为-1.01美元。机构评级：截至2024年11月15日，当前有11家机构对Arcus Biosciences, Inc.目标价做出预测，其中目标均价为34.00美元，其中最低目标价为20.00美元，最高目标价为46.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000238abc18a47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000238abc18a47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS"],"gpt_icon":0},{"id":"2483055610","title":"Arcus Biosciences, Inc.盘中异动 快速跳水5.01%报16.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483055610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483055610?lang=zh_cn&edition=full","pubTime":"2024-11-13 03:30","pubTimestamp":1731439803,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日03时30分，Arcus Biosciences, Inc.股票出现异动，股价快速下挫5.01%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.82%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Kairos Pharma, Ltd.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Genprex, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为564.74%、447.98%、257.04%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Geovax Labs Inc C/Wts 29/09/2025、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为209.30%、105.45%、86.87%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111303300498e4229f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111303300498e4229f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"2482736285","title":"Arcus Biosciences, Inc.盘中异动 早盘快速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482736285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482736285?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:12","pubTimestamp":1731337939,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日23时12分，Arcus Biosciences, Inc.股票出现异动，股价急速拉升5.04%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Revelation Biosciences, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为461.66%、327.53%、121.74%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Bionomics Ltd Ads Each Rep 180 Ord Shs，振幅分别为83.43%、31.82%、30.43%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111123121998e41d20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111123121998e41d20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCUS"],"gpt_icon":0},{"id":"2482043931","title":"Arcus Biosciences, Inc.盘中异动 下午盘大幅拉升5.10%报17.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482043931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482043931?lang=zh_cn&edition=full","pubTime":"2024-11-09 02:28","pubTimestamp":1731090510,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日02时28分，Arcus Biosciences, Inc.股票出现异动，股价快速上涨5.10%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.04%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为751.67%、114.48%、75.20%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为134.44%、87.00%、52.00%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109022830abaeba04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109022830abaeba04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCUS"],"gpt_icon":0},{"id":"1169379605","title":"异动解读 | Arcus Biosciences Inc.盘中大涨6% 机构看好公司前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1169379605","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169379605?lang=zh_cn&edition=full","pubTime":"2024-11-08 02:32","pubTimestamp":1731004351,"startTime":"0","endTime":"0","summary":"今日,生物技术公司Arcus Biosciences Inc.股价盘中大涨6.01%,截至收盘仍维持5.05%的涨幅。RCUS公司的这轮上涨引起了市场广泛关注。分析人士认为,RCUS近期的大涨或与机构投资者给予公司的正面评级有关。数据显示,目前13家机构参与了对RCUS的评级,其中10家机构给予了\"买入\"的评级,占比高达77%。虽然RCUS目前仍处于亏损状态,但投资者看好其成长前景。可以预期,一旦RCUS的核心产品获批上市,公司将迎来营收和利润的大幅增长。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RCUS"],"gpt_icon":0},{"id":"2481132868","title":"Arcus Biosciences, Inc.盘中异动 快速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481132868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481132868?lang=zh_cn&edition=full","pubTime":"2024-11-08 02:24","pubTimestamp":1731003848,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日02时24分，Arcus Biosciences, Inc.股票出现波动，股价急速拉升5.05%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Cingulate Inc C/Wts 10/12/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为929.47%、472.39%、119.16%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Klotho Neurosciences Inc C/Wts 21/06/2029 、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为105.88%、72.18%、68.89%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108022408971a52ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108022408971a52ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"2478770954","title":"Arcus Biosciences, Inc.盘中异动 下午盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478770954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478770954?lang=zh_cn&edition=full","pubTime":"2024-10-26 01:17","pubTimestamp":1729876629,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日01时17分，Arcus Biosciences, Inc.股票出现异动，股价快速下跌5.02%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Iterum Therapeutics Plc、Immunitybio, Inc.涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Iterum Therapeutics Plc较为活跃，换手率分别为839.23%、768.07%、315.53%，振幅较大的相关个股有Iterum Therapeutics Plc、Qualigen Therapeutics, Inc.、Elevai Labs, Inc.，振幅分别为102.56%、91.58%、89.80%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026011710ab747506&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026011710ab747506&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCUS"],"gpt_icon":0},{"id":"2477263194","title":"Arcus Biosciences, Inc.盘中异动 早盘大幅拉升5.31%报18.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477263194","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477263194?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:30","pubTimestamp":1729776650,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时30分，Arcus Biosciences, Inc.股票出现波动，股价大幅拉升5.31%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Cns Pharmaceuticals, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Genprex, Inc.较为活跃，换手率分别为196.37%、91.91%、27.79%，振幅较大的相关个股有Hepion Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.、Erasca, Inc.，振幅分别为12.73%、10.71%、8.14%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421305098e3e3ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421305098e3e3ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RCUS","BK4139"],"gpt_icon":0},{"id":"2477898085","title":"BUZZ--美国股票走势-豪迈航空航天公司、阿拉斯加航空公司、Arcus 生物科学公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2477898085","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477898085?lang=zh_cn&edition=full","pubTime":"2024-10-22 00:12","pubTimestamp":1729527131,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      10月21日 - 华尔街主要股指周一表现低迷，投资者在经历了前一周的大涨之后稍作喘息，等待各大公司的财报，这些财报可能会影响市场是维持纪录高位还是下跌。美东时间11:34，道琼斯工业平均指数  下跌0.9%，报42,881.14点。标普500指数  下跌0.63%，报5827.7点；纳斯达克综合指数  下跌0.50%，报18396.354点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".IXIC","PSN","VFC",".DJI","CRGY","BK4561","DVN","CVX","NEM","LUMN","UDOW","APA","XOM",".SPX","BIOA","HTZ","VVI","HUM","DXD","SCWX","SAVE","CTRA","INDB","AUB","SDOW","MGRX","UPS","JKS","TARA","CI","HWM","AMRX","SEDG","DJX","HD","DDM","SYTA","PLL","KIRK","RH","DOG","RCUS","ALLY","ALK"],"gpt_icon":1},{"id":"2477119867","title":"BUZZ-H.C. Wainwright 给予 Arcus Biosciences \"中性 \"评级后，该公司股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2477119867","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477119867?lang=zh_cn&edition=full","pubTime":"2024-10-21 23:28","pubTimestamp":1729524502,"startTime":"0","endTime":"0","summary":"    10月21日 - ** 药物开发商 Arcus Biosciences    股价下跌 9.41% 至 16.70 美元** H.C. Wainwright给予该公司 \"中性 \"评级，目标价20美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RCUS","MRK"],"gpt_icon":0},{"id":"2477866182","title":"Arcus Biosciences, Inc.盘中异动 早盘快速下挫5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477866182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477866182?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:01","pubTimestamp":1729519305,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时01分，Arcus Biosciences, Inc.股票出现波动，股价大幅跳水5.48%。Arcus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Biovie Inc.、Gri Bio, Inc.、Genprex, Inc.涨幅较大，Gri Bio, Inc.、Genprex, Inc.、Biovie Inc.较为活跃，换手率分别为2295.62%、2066.68%、683.99%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 ，振幅分别为176.03%、154.89%、116.08%。Arcus Biosciences, Inc.公司简介：Arcus Biosciences Inc 是一家临床阶段的生物制药公司。Arcus针对不同类型的癌症进行临床试验，如肺癌、结肠直肠癌、胰腺癌等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021220145971a1623&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021220145971a1623&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RCUS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arcusbio.com","stockEarnings":[{"period":"1week","weight":-0.0991},{"period":"1month","weight":0.0655},{"period":"3month","weight":-0.0619},{"period":"6month","weight":-0.0544},{"period":"1year","weight":-0.0954},{"period":"ytd","weight":-0.1906}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":-0.0071},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.0764},{"period":"1year","weight":0.2517},{"period":"ytd","weight":0.2331}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arcus Biosciences, Inc.于2015年4月30日在特拉华州成立。它们是一家临床阶段的生物制药公司，致力于通过利用开发不足的生物机会创造创新的癌症免疫疗法。具体而言，他们针对特征明确的生物学途径，并提供重要的科学数据支持其调节对癌症的免疫反应的重要性，并且无论是在开发中的分子还是在存在具有次优分布的分子。为了利用这些途径，他们建立了强大而高效的发现能力，以创建和优化高度分化的小分子免疫肿瘤产品候选物。自2015年成立以来，他们已经建立了广泛的小分子和抗体产品候选组合，他们计划共同开发内部组合产品。他们已经启动了两项最先进的候选产品的临床试验，这两种产品预计将在2018年产生数据，并且他们预计在2019年上半年将从他们的第一批产品组合中获得临床数据。他们计划推出两种附加产品候选人到2018年底进入临床试验阶段。Arcus团队的成员共同工作了10多年，在Tularik Inc.，Amgen，Inc.和Flexus Biosciences，Inc.等公司中发现创新的小分子产品候选人。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.041485},{"month":2,"riseRate":0.833333,"avgChangeRate":0.203543},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.065889},{"month":4,"riseRate":0.285714,"avgChangeRate":0.060148},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.033648},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.008856},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.000458},{"month":8,"riseRate":0.571429,"avgChangeRate":0.047883},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.013729},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.047954},{"month":11,"riseRate":0.857143,"avgChangeRate":0.156684},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.014392}],"exchange":"NYSE","name":"Arcus Biosciences Inc.","nameEN":"Arcus Biosciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arcus Biosciences Inc.(RCUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arcus Biosciences Inc.(RCUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arcus Biosciences Inc.,RCUS,Arcus Biosciences Inc.股票,Arcus Biosciences Inc.股票老虎,Arcus Biosciences Inc.股票老虎国际,Arcus Biosciences Inc.行情,Arcus Biosciences Inc.股票行情,Arcus Biosciences Inc.股价,Arcus Biosciences Inc.股市,Arcus Biosciences Inc.股票价格,Arcus Biosciences Inc.股票交易,Arcus Biosciences Inc.股票购买,Arcus Biosciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arcus Biosciences Inc.(RCUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arcus Biosciences Inc.(RCUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}